Yang R - Search Results

1

An advanced non-small cell lung cancer patient with EGFR and KRAS mutations, and PD-L1 positive, benefited from immunotherapy: a case report.

Yang R, Wang D, Li X, Mao K, Wang J, Li P, Shi X, Zhang S, Wang Y. Yang R, et al. Ann Transl Med. 2022 Mar;10(6):381. doi: 10.21037/atm-22-403. Ann Transl Med. 2022. PMID: 35433927 Free PMC article.

2

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.

Tang D, Shen Y, Wang M, Yang R, Wang Z, Sui A, Jiao W, Wang Y. Tang D, et al. Among authors: yang r. Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9. Eur J Cancer Prev. 2013. PMID: 23462458

3

Prospective validation of quantitative NSE mRNA in pleural fluid of non-small cell lung cancer patients.

Tang D, Wang M, Sui A, Wang Y, Yang R, Wang Z, Zhao Y, Jiao W, Shen Y. Tang D, et al. Among authors: yang r. Med Oncol. 2013 Dec;30(4):699. doi: 10.1007/s12032-013-0699-0. Epub 2013 Sep 1. Med Oncol. 2013. PMID: 23996295

4

A facile adenosine triphosphate-responsive nanoplatform for efficacious therapy of esophageal cancer.

Wang J, Xu L, Liu X, Yang R, Wang D. Wang J, et al. Among authors: yang r. Oncol Lett. 2020 Oct;20(4):108. doi: 10.3892/ol.2020.11969. Epub 2020 Aug 10. Oncol Lett. 2020. PMID: 32831927 Free PMC article.

5

Genetic and immune characteristics of multiple primary lung cancers and lung metastases.

Yang R, Li P, Wang D, Wang L, Yin J, Yu B, Li M, Wang S, Wang Y. Yang R, et al. Thorac Cancer. 2021 Oct;12(19):2544-2550. doi: 10.1111/1759-7714.14134. Epub 2021 Sep 12. Thorac Cancer. 2021. PMID: 34510768 Free PMC article.

6

Clinical and genetic characteristics of early-stage multiple primary and independent primary lung adenocarcinoma patients.

Li P, Yang R, Wang D, Wang L, Wang S, Liu C, Li J, Li L, Liu C, Tong Y, Wang Y. Li P, et al. Among authors: yang r. Asia Pac J Clin Oncol. 2022 Oct;18(5):e420-e426. doi: 10.1111/ajco.13743. Epub 2022 Jan 30. Asia Pac J Clin Oncol. 2022. PMID: 35098658

7

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component.

Li P, Liu L, Wang D, Yang R, Xuan Y, Han Y, Wang J, Guo L, Zhang L, Zhang S, Wang Y. Li P, et al. Among authors: yang r. Front Oncol. 2022 Nov 15;12:989349. doi: 10.3389/fonc.2022.989349. eCollection 2022. Front Oncol. 2022. PMID: 36457500 Free PMC article.

8

Investigation of the effect of P14 promoter aberrant methylation on the biological function of human lung cancer cells.

Jia BY, Yang RH, Jiao WJ, Tian KH. Jia BY, et al. Thorac Cancer. 2019 Jun;10(6):1388-1394. doi: 10.1111/1759-7714.13082. Epub 2019 Apr 24. Thorac Cancer. 2019. PMID: 31017733 Free PMC article.

9

Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxia.

Yang R, Guo C. Yang R, et al. Medchemcomm. 2018 Sep 24;9(11):1843-1849. doi: 10.1039/c8md00453f. eCollection 2018 Nov 1. Medchemcomm. 2018. PMID: 30568752 Free PMC article.

10

MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.

Yang R, Wang L, Han M. Yang R, et al. J Cell Biochem. 2019 May;120(5):7222-7228. doi: 10.1002/jcb.27996. Epub 2018 Dec 2. J Cell Biochem. 2019. PMID: 30506837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,695 results

Search Page

Filters